Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure

Michael Murray, James M. Young, Daniel G. Morrow, Michael Weiner, Wanzhu Tu, Shawn C. Hoke, Daniel Clark, Kevin T. Stroupe, Jingwei Wu, Melissa M. Deer, Tina E. Bruner-England, Kevin M. Sowinski, Faye E. Smith, Neil B. Oldridge, Irmina Gradus-Pizlo, Laura L. Murray, D. Craig Brater, Morris Weinberger

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background: Medications can improve the functioning and health-related quality of life of patients with chronic heart failure (CHF) and reduce morbidity, mortality, and costs of treatment. However, patients may not adhere to therapy. Patients with complex medication regimens and low health literacy are at risk for nonadherence. Objective: The primary goal of this project is to develop and assess a multilevel pharmacy-based program to improve patient medication adherence and health outcomes for elderly CHF patients with low health literacy. Methods: In this 4-year, controlled trial, patients aged ≥50 years with a diagnosis of CHF who are being treated at Wishard Health Services (Indianapolis, Indiana) are randomly assigned to pharmacist intervention or usual care. Intervention patients receive 9 months of pharmacist support and 3 months of postintervention follow-up. The intervention involves a pharmacist providing verbal and written education, icon-based labeling of medication containers, and therapeutic monitoring. The pharmacist identifies patients' barriers to appropriate drug use, coaches them on overcoming these barriers, and coordinates medication use issues with their primary care providers. Daily updates of relevant monitoring data are delivered via an electronic medical record system and stored in a personal computer system designed to support pharmacist monitoring and facilitate documentation of interventions. To measure medication adherence objectively, electronic monitoring lids are used on all CHF medications for patients in both study groups. Other assessments include self-reported medication adherence, results of echocardiography (eg, ejection fraction), brain natriuretic peptide concentrations, and health-related quality of life. Health services utilization, refill adherence, and cost data derive from electronic medical records. After completion of this study, the data can be used to assess the effectiveness and cost-effectiveness of our intervention. Results: One hundred twenty-two patients have been assigned to receive the intervention and 192 to receive usual care. Conclusions: Our study aims to improve patients' knowledge and self-management of their medication and to improve medication monitoring in a multilevel pharmacy-based intervention. By doing so, we intend that the intervention will improve the health outcomes of elderly patients with CHF.

Original languageEnglish
Pages (from-to)53-65
Number of pages13
JournalAmerican Journal Geriatric Pharmacotherapy
Volume2
Issue number1
DOIs
StatePublished - Mar 2004

Fingerprint

Randomized Controlled Trials
Heart Failure
Pharmaceutical Preparations
Pharmacists
Medication Adherence
Health Literacy
Electronic Health Records
Health Services
Quality of Life
Knowledge Management
Brain Natriuretic Peptide
Computer Systems
Health
Microcomputers
Patient Compliance
Self Care
Documentation
Health Care Costs
Cost-Benefit Analysis
Echocardiography

Keywords

  • Heart failure
  • Medication adherence
  • Outcomes research

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Geriatrics and Gerontology

Cite this

Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure. / Murray, Michael; Young, James M.; Morrow, Daniel G.; Weiner, Michael; Tu, Wanzhu; Hoke, Shawn C.; Clark, Daniel; Stroupe, Kevin T.; Wu, Jingwei; Deer, Melissa M.; Bruner-England, Tina E.; Sowinski, Kevin M.; Smith, Faye E.; Oldridge, Neil B.; Gradus-Pizlo, Irmina; Murray, Laura L.; Brater, D. Craig; Weinberger, Morris.

In: American Journal Geriatric Pharmacotherapy, Vol. 2, No. 1, 03.2004, p. 53-65.

Research output: Contribution to journalArticle

Murray, M, Young, JM, Morrow, DG, Weiner, M, Tu, W, Hoke, SC, Clark, D, Stroupe, KT, Wu, J, Deer, MM, Bruner-England, TE, Sowinski, KM, Smith, FE, Oldridge, NB, Gradus-Pizlo, I, Murray, LL, Brater, DC & Weinberger, M 2004, 'Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure', American Journal Geriatric Pharmacotherapy, vol. 2, no. 1, pp. 53-65. https://doi.org/10.1016/S1543-5946(04)90007-4
Murray, Michael ; Young, James M. ; Morrow, Daniel G. ; Weiner, Michael ; Tu, Wanzhu ; Hoke, Shawn C. ; Clark, Daniel ; Stroupe, Kevin T. ; Wu, Jingwei ; Deer, Melissa M. ; Bruner-England, Tina E. ; Sowinski, Kevin M. ; Smith, Faye E. ; Oldridge, Neil B. ; Gradus-Pizlo, Irmina ; Murray, Laura L. ; Brater, D. Craig ; Weinberger, Morris. / Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure. In: American Journal Geriatric Pharmacotherapy. 2004 ; Vol. 2, No. 1. pp. 53-65.
@article{f54520d506f64cd7bf00831f803354fa,
title = "Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure",
abstract = "Background: Medications can improve the functioning and health-related quality of life of patients with chronic heart failure (CHF) and reduce morbidity, mortality, and costs of treatment. However, patients may not adhere to therapy. Patients with complex medication regimens and low health literacy are at risk for nonadherence. Objective: The primary goal of this project is to develop and assess a multilevel pharmacy-based program to improve patient medication adherence and health outcomes for elderly CHF patients with low health literacy. Methods: In this 4-year, controlled trial, patients aged ≥50 years with a diagnosis of CHF who are being treated at Wishard Health Services (Indianapolis, Indiana) are randomly assigned to pharmacist intervention or usual care. Intervention patients receive 9 months of pharmacist support and 3 months of postintervention follow-up. The intervention involves a pharmacist providing verbal and written education, icon-based labeling of medication containers, and therapeutic monitoring. The pharmacist identifies patients' barriers to appropriate drug use, coaches them on overcoming these barriers, and coordinates medication use issues with their primary care providers. Daily updates of relevant monitoring data are delivered via an electronic medical record system and stored in a personal computer system designed to support pharmacist monitoring and facilitate documentation of interventions. To measure medication adherence objectively, electronic monitoring lids are used on all CHF medications for patients in both study groups. Other assessments include self-reported medication adherence, results of echocardiography (eg, ejection fraction), brain natriuretic peptide concentrations, and health-related quality of life. Health services utilization, refill adherence, and cost data derive from electronic medical records. After completion of this study, the data can be used to assess the effectiveness and cost-effectiveness of our intervention. Results: One hundred twenty-two patients have been assigned to receive the intervention and 192 to receive usual care. Conclusions: Our study aims to improve patients' knowledge and self-management of their medication and to improve medication monitoring in a multilevel pharmacy-based intervention. By doing so, we intend that the intervention will improve the health outcomes of elderly patients with CHF.",
keywords = "Heart failure, Medication adherence, Outcomes research",
author = "Michael Murray and Young, {James M.} and Morrow, {Daniel G.} and Michael Weiner and Wanzhu Tu and Hoke, {Shawn C.} and Daniel Clark and Stroupe, {Kevin T.} and Jingwei Wu and Deer, {Melissa M.} and Bruner-England, {Tina E.} and Sowinski, {Kevin M.} and Smith, {Faye E.} and Oldridge, {Neil B.} and Irmina Gradus-Pizlo and Murray, {Laura L.} and Brater, {D. Craig} and Morris Weinberger",
year = "2004",
month = "3",
doi = "10.1016/S1543-5946(04)90007-4",
language = "English",
volume = "2",
pages = "53--65",
journal = "American Journal Geriatric Pharmacotherapy",
issn = "1543-5946",
publisher = "Excerpta Medica",
number = "1",

}

TY - JOUR

T1 - Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure

AU - Murray, Michael

AU - Young, James M.

AU - Morrow, Daniel G.

AU - Weiner, Michael

AU - Tu, Wanzhu

AU - Hoke, Shawn C.

AU - Clark, Daniel

AU - Stroupe, Kevin T.

AU - Wu, Jingwei

AU - Deer, Melissa M.

AU - Bruner-England, Tina E.

AU - Sowinski, Kevin M.

AU - Smith, Faye E.

AU - Oldridge, Neil B.

AU - Gradus-Pizlo, Irmina

AU - Murray, Laura L.

AU - Brater, D. Craig

AU - Weinberger, Morris

PY - 2004/3

Y1 - 2004/3

N2 - Background: Medications can improve the functioning and health-related quality of life of patients with chronic heart failure (CHF) and reduce morbidity, mortality, and costs of treatment. However, patients may not adhere to therapy. Patients with complex medication regimens and low health literacy are at risk for nonadherence. Objective: The primary goal of this project is to develop and assess a multilevel pharmacy-based program to improve patient medication adherence and health outcomes for elderly CHF patients with low health literacy. Methods: In this 4-year, controlled trial, patients aged ≥50 years with a diagnosis of CHF who are being treated at Wishard Health Services (Indianapolis, Indiana) are randomly assigned to pharmacist intervention or usual care. Intervention patients receive 9 months of pharmacist support and 3 months of postintervention follow-up. The intervention involves a pharmacist providing verbal and written education, icon-based labeling of medication containers, and therapeutic monitoring. The pharmacist identifies patients' barriers to appropriate drug use, coaches them on overcoming these barriers, and coordinates medication use issues with their primary care providers. Daily updates of relevant monitoring data are delivered via an electronic medical record system and stored in a personal computer system designed to support pharmacist monitoring and facilitate documentation of interventions. To measure medication adherence objectively, electronic monitoring lids are used on all CHF medications for patients in both study groups. Other assessments include self-reported medication adherence, results of echocardiography (eg, ejection fraction), brain natriuretic peptide concentrations, and health-related quality of life. Health services utilization, refill adherence, and cost data derive from electronic medical records. After completion of this study, the data can be used to assess the effectiveness and cost-effectiveness of our intervention. Results: One hundred twenty-two patients have been assigned to receive the intervention and 192 to receive usual care. Conclusions: Our study aims to improve patients' knowledge and self-management of their medication and to improve medication monitoring in a multilevel pharmacy-based intervention. By doing so, we intend that the intervention will improve the health outcomes of elderly patients with CHF.

AB - Background: Medications can improve the functioning and health-related quality of life of patients with chronic heart failure (CHF) and reduce morbidity, mortality, and costs of treatment. However, patients may not adhere to therapy. Patients with complex medication regimens and low health literacy are at risk for nonadherence. Objective: The primary goal of this project is to develop and assess a multilevel pharmacy-based program to improve patient medication adherence and health outcomes for elderly CHF patients with low health literacy. Methods: In this 4-year, controlled trial, patients aged ≥50 years with a diagnosis of CHF who are being treated at Wishard Health Services (Indianapolis, Indiana) are randomly assigned to pharmacist intervention or usual care. Intervention patients receive 9 months of pharmacist support and 3 months of postintervention follow-up. The intervention involves a pharmacist providing verbal and written education, icon-based labeling of medication containers, and therapeutic monitoring. The pharmacist identifies patients' barriers to appropriate drug use, coaches them on overcoming these barriers, and coordinates medication use issues with their primary care providers. Daily updates of relevant monitoring data are delivered via an electronic medical record system and stored in a personal computer system designed to support pharmacist monitoring and facilitate documentation of interventions. To measure medication adherence objectively, electronic monitoring lids are used on all CHF medications for patients in both study groups. Other assessments include self-reported medication adherence, results of echocardiography (eg, ejection fraction), brain natriuretic peptide concentrations, and health-related quality of life. Health services utilization, refill adherence, and cost data derive from electronic medical records. After completion of this study, the data can be used to assess the effectiveness and cost-effectiveness of our intervention. Results: One hundred twenty-two patients have been assigned to receive the intervention and 192 to receive usual care. Conclusions: Our study aims to improve patients' knowledge and self-management of their medication and to improve medication monitoring in a multilevel pharmacy-based intervention. By doing so, we intend that the intervention will improve the health outcomes of elderly patients with CHF.

KW - Heart failure

KW - Medication adherence

KW - Outcomes research

UR - http://www.scopus.com/inward/record.url?scp=2342435037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342435037&partnerID=8YFLogxK

U2 - 10.1016/S1543-5946(04)90007-4

DO - 10.1016/S1543-5946(04)90007-4

M3 - Article

VL - 2

SP - 53

EP - 65

JO - American Journal Geriatric Pharmacotherapy

JF - American Journal Geriatric Pharmacotherapy

SN - 1543-5946

IS - 1

ER -